NIAID-Funded Adjuvant Improves Typhoid Vaccine Candidate in Animal

An investigational typhoid vaccine containing a component developed with NIAID funding may overcome some of the shortcomings of available typhoid vaccines, according to a paper published in the journal Vaccine in June.

Frontiers Polyphosphazenes as Adjuvants for Animal Vaccines and

Expansion of multicytokine-producing vaccine-specific CD4 + T

Frontiers Nanomaterials-based vaccines to target intracellular

Global Innovations (International Cooperation

The Role of Vaccines in Combating Antimicrobial Resistance

Mucosal vaccines — fortifying the frontiers

Key roles of adjuvants in modern vaccines - Document - Gale

Vaccine Adjuvant Discovery and Mechanistic Research

Key roles of adjuvants in modern vaccines - Document - Gale

The find of COVID-19 vaccine: Challenges and opportunities

Adjuvant Development NIAID: National Institute of Allergy and

Controlled Human Infection Models To Accelerate Vaccine

A Co-abundant Gene Analysis for Identification of Gut Microbial

Vaccines platforms and COVID-19: what you need to know